Fridley, MN, United States of America

Rohaizah I James

This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rohaizah I James. Retrieved from https://idiyas.com/inventor/rohaizah-i-james

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rohaizah I James: Innovator in Hematopoietic Stem Cell Research

Introduction

Rohaizah I James is a notable inventor based in Fridley, Minnesota. He has made significant contributions to the field of hematopoietic stem cell research. His innovative work focuses on improving the efficiency of stem cell engraftment, which is crucial for various medical treatments.

Latest Patents

Rohaizah I James holds a patent for a method titled "Method for selective engraftment of drug-resistant hematopoietic stem cells." This method aims to enhance the efficiency of hematopoietic stem cell engraftment in vivo. His work in this area is vital for advancing treatment options for patients requiring stem cell therapies.

Career Highlights

James is affiliated with the Regents of the University of Minnesota, where he continues to engage in groundbreaking research. His dedication to improving medical outcomes through innovative techniques has established him as a respected figure in his field.

Collaborations

Some of his notable coworkers include Chad May and R. Scott McIvor. Their collaborative efforts contribute to the advancement of research in hematopoietic stem cells and related therapies.

Conclusion

Rohaizah I James is a pioneering inventor whose work in hematopoietic stem cell engraftment is making a significant impact in the medical field. His contributions are essential for the future of stem cell therapies and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…